Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TechnologyAdvice

- PMLiVE

Denmark: rising pharma spend amid healthcare cost-containment

Denmark’s historically low rate of pharma spending is rising steadily, despite a focus on wider cuts in healthcare

National Institute for Health and Care Excellence NICE logo

UK backs use of drugs to prevent breast cancer

Daily use of tamoxifen or raloxifene recommended in at-risk women

- PMLiVE

Boehringer files Pradaxa for new VTE indication in Europe

Seeks to add to anticoagulant’s approvals

- PMLiVE

EMA commits to disclosure of data from trials

Seeks feedback on clinical trial data access policy

- PMLiVE

Eisai pulls epilepsy drug Fycompa in Germany

Based on unfavourable assessment by pricing body

- PMLiVE

ADA: Sanofi eyes 2014 submissions for Lantus successor

Releases first phase III data for U300 formulation of insulin glargine

- PMLiVE

ADA: Novo Nordisk steps up Lantus challenge with new Tresiba data

But still faces at least a three-year wait for US approval

- PMLiVE

Lundbeck to cut 50 jobs in Europe

Part of restructuring operations to cope with patent loss for Cipralex/ Lexapro

- PMLiVE

Chips can be good for your health

No-holds barred – and that’s exactly WHY these awards are getting healthcare creatives thinking…

- PMLiVE

Owen Mumford promotes Richard Simmonds to lead global marketing team

Part of management restructure at medical devices company

- PMLiVE

Brazil’s healthcare conundrum

A rising middle class has seen healthcare challenges shift from a lack of affordability to discussions about willingness to spend

- PMLiVE

Astellas wins EU approval for prostate cancer drug Xtandi

Will compete with J&J’s big-selling Zytiga

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links